Sonoma Biotherapeutics logo

Sonoma Biotherapeutics

South San Francisco, CA

Sonoma Biotherapeutics is a company invloved the development of adoptive Treg therapies cell for autoimmune and degenerative diseases. Using next generation genome editing and target-specific cell therapy, Sonoma is focused on developing its best-in-class platform across the entire spectrum of Treg cell therapeutic capabilities. Founded by pioneers in Treg biology and cell therapy, the company brings together leading expertise and proprietary methodologies for the discovery and development of disease modifying and curative therapies.

sonomabio.com

Company Details

Founded

2020

Employees

Between 100 - 500 employees

Raised

$365,000,000

Headquarters Location

South San Francisco, CA

Public

No

Acquired

No

CEO

Jeff BluestoneJeff Bluestone

Founders

Jeffrey Bluestone
Jeffrey Bluestone
Qizhi Tang
Qizhi Tang
Fred Ramsdell
Fred Ramsdell
Alexander Rudensky
Alexander Rudensky

Company Collections

These are collections Sonoma Biotherapeutics is a part of. Click on the collection name to view similar companies.

Sonoma Biotherapeutics' Investors

Sonoma Biotherapeutics' Industries

Company Collections For Sonoma Biotherapeutics